COMPARISON OF TEMPORAL TRENDS OF GLOBAL BURDEN OF TRACHEA, BRONCIHAL, AND LUNG CANCER
-
Published:2022-12-17
Issue:
Volume:
Page:
-
ISSN:2149-3391
-
Container-title:Giresun Üniversitesi İktisadi ve İdari Bilimler Dergisi
-
language:tr
-
Short-container-title:GİİBDE
Author:
ÇETİNTÜRK İskender, YİĞİT Vahit1
Affiliation:
1. SÜLEYMAN DEMİREL ÜNİVERSİTESİ
Abstract
Trachea, bronchial, and lung (TBL) cancers are significant public health problems among the leading causes of death in Turkey and the world. In this study, it was aimed to determine and evaluate the temporal trends of incidence, mortality, and DALY rates of TBA cancers between 1990 and 2019. Mortality-Incidence Ratio (MIR) and Joinpoint Regression Analysis (JRA) methods were used in this study. Incidence, mortality, and disability-adjusted life-years were used as variables in the study. The temporal trends of TBL cancers were compared between the global, Turkey, and Socio-Demographic Index (SDI) groups. In this study, it was determined that the age-standardized global burden of TBL cancers tended to decrease between 1990 and 2019. While the burden of TBL cancers tended to decline in high SDI countries during this period, it tended to increase in low SDI countries. In Turkey, while the TBL cancers burden decreased until 2005, it increased after 2006. While the global cancer burden of TBL tended to decline in men, it tended to increase in women during this period. According to the data obtained from the research findings, the burden of TBL cancers tends to decrease globally. However, it tends to increase in low and low-middle SDI group countries. To reduce the TBL global cancer burden, it is recommended that health policies should be developed in both Turkey and international health systems for fair access to cancer treatment.
Publisher
Journal of Economics and Administrative Sciences, Giresun University
Reference35 articles.
1. Abbafati, C., Abbas, K. M., Abbasi-Kangevari., … Wiangkham, T. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9 2. Ahmad, O. B., Boschi-pinto, C., & Lopez, A. D. (2001). Age standardization of rates: a new WHO standard. GPE Discussion Paper Series, 31, 1–14. http://www.who.int/healthinfo/paper31.pdf 3. Almasi, Z., Salehiniya, H., Amoori, N., & Enayatrad, M. (2016). Epidemiology characteristics and trends of lung cancer incidence in Iran. Asian Pacific Journal of Cancer Prevention, 17(2), 557–562. https://doi.org/10.7314/APJCP.2016.17.2.557 4. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492 5. Cayuela, A., Rodríguez-Domínguez, S., López-Campos, J. L., & Vigil, E. (2008). Lung cancer mortality trends by geographical area in Spanish women, 1980-2005. International Journal of Tuberculosis and Lung Disease, 12(4), 453-457.
|
|